Literature DB >> 23426830

Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.

Melissa Pawelczak1, Lisa Kenigsberg, Sarah Milla, Ying-Hua Liu, Bina Shah.   

Abstract

CONTEXT: Serum anti-Müllerian hormone (AMH) is linked to the ovarian follicle pool. Little is known about the relationship between serum AMH and ovarian ultrasound (US) features in adolescents with polycystic ovary syndrome (PCOS).
OBJECTIVES: To confirm that serum AMH is elevated in adolescents with PCOS and to correlate serum AMH with ovarian US features in this population are the objectives of this study.
DESIGN: A retrospective chart review of clinical, biochemical, and ultrasonographic data in adolescents with PCOS and normal controls is the design of the study. Serum AMH was measured and compared between groups and correlated with ovarian US findings.
SETTING: The study was done in two urban tertiary academic medical centers. PARTICIPANTS: Study groups included 23 adolescent females with PCOS and 12 age and BMI-matched female controls. MAIN OUTCOME MEASURES: We hypothesized that serum AMH would be elevated in the PCOS group compared with the controls and would positively correlate with the follicle number, distribution, and ovarian volume.
RESULTS: Serum AMH was 6.78±3.55 ng/mL in the PCOS group vs. 3.38±1.48 ng/mL in the controls (p=0.0004). AMH positively correlated with ovarian volume (left ovary r=0.65, p=0.0007, right ovary r=0.55, p=0.0065) and peripheral follicle distribution (p=0.0027). Ten or more follicles were observed in 83% of USs.
CONCLUSIONS: There is a positive relationship between serum AMH and ovarian volume as well as peripheral follicular distribution in adolescents with PCOS. Our findings support the use of serum AMH as a useful marker to reflect ovarian US features typical of PCOS in cases where accurate USs are not available and for follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23426830      PMCID: PMC3763943          DOI: 10.1515/jpem-2012-0013

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  55 in total

1.  Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate.

Authors:  Kamel Abdelhakim Mohamed; W A R Davies; Hany Lashen
Journal:  Fertil Steril       Date:  2006-09-14       Impact factor: 7.329

Review 2.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

3.  Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.

Authors:  Didier Dewailly; Pascal Pigny; Benoît Soudan; Sophie Catteau-Jonard; Christine Decanter; Edouard Poncelet; Alain Duhamel
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

4.  Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology.

Authors:  William L Ledger
Journal:  J Clin Endocrinol Metab       Date:  2010-12       Impact factor: 5.958

5.  Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.

Authors:  Antonio La Marca; Raoul Orvieto; Simone Giulini; Valerio Maria Jasonni; Annibale Volpe; Vincenzo De Leo
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

6.  Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin.

Authors:  Angela Falbo; Morena Rocca; Tiziana Russo; Antonietta D'Ettore; Achille Tolino; Fulvio Zullo; Francesco Orio; Stefano Palomba
Journal:  J Ovarian Res       Date:  2010-07-21       Impact factor: 4.234

7.  Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome.

Authors:  A A Kyei-Mensah; S LinTan; J Zaidi; H S Jacobs
Journal:  Hum Reprod       Date:  1998-06       Impact factor: 6.918

8.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

Authors:  Joop S E Laven; Annemarie G M G J Mulders; Jenny A Visser; Axel P Themmen; Frank H De Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

9.  Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages.

Authors:  K Ruutiainen; R Erkkola; M A Grönroos; K Irjala
Journal:  Fertil Steril       Date:  1988-08       Impact factor: 7.329

Review 10.  Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

Authors:  Laura Pellatt; Suman Rice; Helen D Mason
Journal:  Reproduction       Date:  2010-03-05       Impact factor: 3.906

View more
  11 in total

1.  Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.

Authors:  K A Kissell; M R Danaher; E F Schisterman; J Wactawski-Wende; K A Ahrens; K Schliep; N J Perkins; L Sjaarda; J Weck; S L Mumford
Journal:  Hum Reprod       Date:  2014-06-12       Impact factor: 6.918

2.  Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.

Authors:  Lisa E Kenigsberg; Chhavi Agarwal; Sanghun Sin; Keivan Shifteh; Carmen R Isasi; Rebecca Crespi; Janeta Ivanova; Susan M Coupey; Rubina A Heptulla; Raanan Arens
Journal:  Fertil Steril       Date:  2015-09-03       Impact factor: 7.329

Review 3.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

4.  Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.

Authors:  Aviva B Sopher; Galina Grigoriev; Diana Laura; Tamara Cameo; Jodi P Lerner; R Jeffrey Chang; Donald J McMahon; Sharon E Oberfield
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

5.  Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women.

Authors:  Hafza Tola; Mohammed Abbas; Elsir Abu Alhassan; Nassr Eldin Shrif; Mohammed Rida
Journal:  Open Access Maced J Med Sci       Date:  2018-07-17

6.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

7.  The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.

Authors:  Chia Lin Chang; Shang Yu Huang; Ya Chiung Hsu; Tzu Hsuan Chin; Yung Kuei Soong
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

8.  Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay.

Authors:  Helen Jopling; Allen Yates; Nicholas Burgoyne; Katharine Hayden; Christopher Chaloner; Lesley Tetlow
Journal:  Endocrinol Diabetes Metab       Date:  2018-07-18

Review 9.  Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

Authors:  Marie Lindhardt Johansen; Casper P Hagen; Trine Holm Johannsen; Katharina M Main; Jean-Yves Picard; Anne Jørgensen; Ewa Rajpert-De Meyts; Anders Juul
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

10.  Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Authors:  Aylin Yetim; Çağcıl Yetim; Firdevs Baş; Oğuz Bülent Erol; Gülnaz Çığ; Ahmet Uçar; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.